Reverse transformation of human mammary carcinoma cells

Anticancer Research

Volumn 19, Issue 6 B, 1999, Pages 5119-5125

  Luebbe, Lieselotte ^a   Schenk, Joerg A ^b   Naundorf, Helga ^b   Karsten, Uwe ^b   Wunderlich, Volker ^b  

^a Carl Thiem Hospital   (Germany)

^b MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

Author keywords

Daunorubicin; Differentiation; Drug selection; Human mammary carcinoma cells; Neoplastic phenotype

Indexed keywords

ANTIBODY; DAUNORUBICIN;

ARTICLE; BREAST CARCINOMA; CARCINOGENICITY; CELL SELECTION; CELL STRUCTURE; CELL TRANSFORMATION; CONTROLLED STUDY; CROSS RESISTANCE; DRUG RESISTANCE; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; BREAST NEOPLASMS; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; MIDDLE AGED; NEOPLASM TRANSPLANTATION; TUMOR CELLS, CULTURED;

EID: 0033383006     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Biedler JL, Riehm H, Peterson RHF, Spengler BA: Membrane-mediated drug resistance and phenotypic reversion to normal growth behavior of Chinese hamster cells. J Natl Cancer Inst 55: 671-680, 1975.
2. Biedler JL: Drug resistance: genotype versus phenotype - Thirty-second GHA Clowes Memorial Award Lecture. Cancer Res 54: 666-678, 1994.
3. Biedler JL, Spengler BA: Reverse transformation of multidrug-resistant cells. Cancer Metastasis Rev 13: 191-207, 1994.
4. Bénard J, Da Silva J, Teyssier J-R, Riou G: Over-expression of MDR1 gene with no DNA amplification in a multiple-drug-resistant human ovarian carcinoma cell line. Int J Cancer 43: 471-477, 1989.
5. Hill AB, Beck WT, Trent JM: Cytogenetic and molecular characterization of rumors in nude mice derived from a multidrug-resistant human leukemia cell line. Cancer Res 48: 393-398, 1988.
6. Sanfilippo O, Ronchi E, De Marco C, Di Fronzo G, Silvestrini R: Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine. Eur J Cancer 27: 155-158, 1991.
7. Brotherick I, Shenton BK, Egan M, Cunliffe WE, Browell DA, Lunt LG, Young JR, Higgs MJ: Examination of multidrug resistance in cell lines and primary breast tumours by flow cytometry. Europ J Cancer 32A: 2334-2341, 1996.
8. Luebbe L, Jungblut P, Naundorf H, Wunderlich V: Daunomycin induces differential phenotypes in cells of a human mammary tumor. J Exp Clin Cancer Res 14, Suppl 1: 10-12, 1995.
9. Widmaier R, Wildner GP, Papsdorf G, Graffi I: Über eine neue, in vitro unbegrenzt wachsende Zellinie, MaTu, von Mamma-Tumorzellen des Menschen. Arch Geschwulstforsch 44: 1-10, 1974.
10. Fairchild CR, Ivy SP, Kao-Shan CS, Whang-Peng J, Rosen N, Israel MA, Melera PW, Cowan KH, Goldsmith ME: Isolation of amplified and overexpressed DNA sequences from adriamycin-resistant human breast cancer cells. Cancer Res 47: 5141-5148, 1987.
11. Karsten U, Papsdorf G, Pauly A, Vojtesek B, Moll R, Lane EB, Clausen H, Stosiek P, Kasper M: Subtypes of non-transformed human mammary epithelial cells cultured in vitro: histo-blood group antigen H type 2 defines basal cell-derived cells. Differentiation 54: 55-66, 1993.
12. MacPherson J, Montagnier L: Agar suspension culture for the selective assay of cells transformed by polyoma virus. Virology 23: 291-294, 1964.
13. Roninson IB, ed. Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells. New York and London, Plenum Press, 1991.
14. Boyer B, Tucker GC, Vallis AM, Franke WW, Thiery JP: Rearrangements of desmosomal and cytoskeletal proteins during the transition from epithelial to fibroblastoid organization in cultured rat bladder carcinoma cells. J Cell Biol 109: 1495-1509, 1989.
15. Mickley LA, Bates SE, Richert ND, Currier S, Tanaka S, Foss F, Rosen N, Fojo AT: Modulation of the expression of a multidrug resistance gene (mdr-1/P-glycoprotein) by differentiating agents. J Biol Chem 264: 18031-18040, 1989.
16. Chin KV, Pastan I, Gottesman MM: Function and regulation of the human multidrug resistance gene. Adv Cancer Res 60: 157-180, 1993.
17. Su L, Morgan PR, Lane EB: Expression of cytokeratin messenger RNA versus protein in the normal mammary gland and in breast cancer. Hum Pathol 27: 800-806, 1996.
18. Bauman PA, Dalton WS, Anderson JM, Cress AE: Expression of cytokeratin confers multiple drug resistance. Proc Natl Acad Sci USA 91: 5311-5314, 1994.
19. Cress AE, Dalton WS: Multiple drug resistance and intermediate filaments. Cancer Metastasis Rev 15: 499-506, 1996.
20. Mickley LA, Spengler BA, Knutsen TA, Biedler JL, Fojo T: Gene rearrangement: a novel mechanism for MDR-1 gene activation. J Clin Invest 99: 1947-1957, 1997.